Denosumab Use for Osteoporosis May Reduce Risk of Type 2 Diabetes
![Close up of doctor holding syringe, denosumab medical injection concept](https://www.brighamhealthonamission.org/wp-content/uploads/2023/08/syringe-medical-injectio.jpg)
Clinical guidelines recommend denosumab for people with osteoporosis with a high fracture risk. Now, researchers at Brigham and Women’s Hospital have associated denosumab use with a 32% decreased risk of type 2 diabetes compared with the use of an oral bisphosphonate.
Read More...